Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome

Clinical trial NCT00604201 · COMPLETED

Trial details

NCT number: NCT00604201
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)Severe Aplastic Anemia (SAA)

Start date: 2008-05-21
Primary completion: 2016-10-25
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.